SHEZF'ün son EPS'si beklentilerle karşılaştırıldığında nasıldı?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. SHEZF'ün son çeyrekteki geliri nasıl performans gösterdi?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.'in gelir tahmini nedir?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.'in kazanç kalite puanı nedir?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. kazançlarını ne zaman rapor eder?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.'in beklenen kazançları nelerdir?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. kazanç beklentilerini aştı mı?
Önemli İstatistikler
Önceki Kapanış
$0.4696
Açılış fiyatı
$0.7206
Günün Aralığı
$0.4696 - $0.7206
52 haftalık aralık
$0.4696 - $0.7206
İşlem hacmi
25
Ort.Hacim
0
EPS (TTM)
-0.02
Dividend yield
--
Piyasa Değeri
$103.3M
SHENZHEN HEPALINK PHARMACEUTICA nedir?
Shenzhen Hepalink Pharmaceutical Group Co Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Shenzhen, Guangdong and currently employs 1,926 full-time employees. The company went IPO on 2010-05-06. Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based company primarily engaged in the heparin industry chain, contract development and manufacturing organization (CDMO) of biological macromolecules, and the investment, development, and commercialization of innovative drugs. The firm operates four segments. The Pharmaceutical Formulations segment manufactures and sells enoxaparin sodium injection and others. The Active Pharmaceutical Ingredients (APIs) segment manufactures and sells standard heparin APIs, enoxaparin APIs and others. The CDMO segment provides process development services for pharmaceutical intermediates and APIs, including process research, optimization, analytical testing, and formulation research. The Other segment engages in other product businesses, such as pancreatic enzymes and casings. The firm conducts its business in the domestic and overseas markets.